A randomised controlled trial: Outcomes of bladder rehabilitation in persons with multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 9, 2010, Pages 1033-1038

  Khan, F ^a   Pallant, J F ^b   Pallant, J I ^c   Brand, C ^d   Kilpatrick, T J ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Biostatistics and Research Consultancy   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER COMPLIANCE; BLADDER DYSFUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; URINE INCONTINENCE; URINE RETENTION; BLADDER DISEASE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT EDUCATION AS TOPIC; SEVERITY OF ILLNESS INDEX; URINARY BLADDER DISEASES;

EID: 77956640403     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.206623     Document Type: Article

References (37)

1. Khan F, Pallant J, Shea T, et al. Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian cohort. Disabil Rehabil 2009;31:1576.
2. de Seze M, Ruffion A, Denys P, et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007;13:915-28.
3. Khan F, McPhail T, Brand C, et al. Multiple sclerosis: Disability profile and quality of life in an Australian Community Cohort. Int J Rehabil Res 2006;29:87-96.
4. Fowler CJ, Panicker JN, Drake M, et al. A UK Consensus on the management of the bladder in multiple sclerosis. JNNP 2009;80:470-7.
5. Nicholas RS, Friede T, Hollis S, et al. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev 2009;1:CD004193.
6. Giannantoni A, Scivoletto G, Di StaSi SM, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 1999;80:437-41.
7. Khan F, Pallant J. Use of International Classification of Functioning and health (ICF) to describe patient reported disability in multiple sclerosis and identification of relevant environmental factors. J Rehabil Med 2007;39:63-70.
8. World Health Organization (WHO). International Classification of Functioning, Disability and Health (ICF). Geneva: WHO, 2001.
9. Khan F, Pallant J. Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis. Disabil Rehabil 2007;29:205-13.
10. Green JP, Smoker I, Ho MT, et al. Urinary incontinence in subacute care: a retrospective analysis of clinical outcomes and costs. Med J Aust 2003;178:550-3.
11. Khan F, Turner Stokes L, Ng L, et al. Multidisciplinary rehabilitation for adults with multiple sclerosis (review). Cochrane Database Syst Rev 2007;2:CD006036.
12. Khan F, Pallant JF, Brand C, et al. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008;79:1230-5.
13. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
14. McDonald W, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple sclerosis. Ann Neurol 2001;50:121-7.
15. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub committee of the International Continence Society. Am J Obstet Gynaecol 2002;187:116-26.
16. Shumaker S, Wyman J, Uebersax J, et al. Health related quality of life measures for women with urinary incontinence: The Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994;3:291-306.
17. Sharrack B, Hughes RAC. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-33.
18. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol 1992;148:1549-57.
19. Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995;14:131-39.
20. Vickers J, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-4.
21. Field A. Discovering Statistics using SPSS, 2nd edn. London: Sage Publications, 2005.
22. Cohen J. Statistical power analysis for the behavioural sciences, 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
23. Shih WJ. Problems dealing with missing data and informative censoring in clinical trials. Curr Controlled Trials Cardiovas Med 2002;3:4.
24. Norvedt MW, Riise T, Frugard J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13:106-12.
25. Grasso MG, Troisi E, Rizzi F, et al. Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcomes study. Mult Scler 2005;11:719-24.
26. Amato MP, Ponziani G. A prospective study on prognosis of multiple sclerosis. Neurol Sci 2000;21:S831-8.
27. Vahter L, Zopp I, Kreegipuu M, et al. Clean intermittent self catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction. Mult Scler 2009;15:379-84.
28. Langdon DW, Thompson AJ. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999;5:94-100.
29. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005;4:643-52.
30. Norris JP, Staskin DR. History, physical examination and classification of neurogenic voiding dysfunction. Urol Clin North Am 1996;23:337-43.
31. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology 2003;62:20-7.
32. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs 2003;63:153-66.
33. Svatek R, Roche V, Thornberg J, et al. Normative values for the American Urological Association Symptom Index (AUA7) and Short Form Urogenital Distress Inventory (UDI6) in patients 65 and older presenting for non urological care. Neurourol Urodyn 2005;24:606-10.
34. Wynia K, Middel B, van Dijk JP, et al. The impact of disabilities on quality of life in people with multiple sclerosis. Mult Scler 2008;14:927-80.
35. Harvey MA, Kristjansson B, Griffith D, et al. The Incontinence Impact Questionnaire and the Urogenital Distress Inventory: a revisit of their validity in women without a urodynamics diagnosis. Am J Obstet Gynecol 2001;185:25-31.
36. Costello L, O'Rourke K, Kearny H, et al. The patient knows best significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS29). J Neurol Neurosurg Psychiatry 2007;78:841-4.
37. Sprangers MA, Schwartz CE. Integrating response shift into health related quality of life research: a theoretical model. Soc Sci Med 1999;48:1507-15.